Eisaku Yoshida
Chiba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Evaluation of variations in urine laminin-γ2 monomer in non-muscle-invasive bladder cancer before and after transurethral resection of the bladder tumor.
Journal: BMC cancer
Published: February 25, 2025
Serum laminin γ2 monomer as a predictive biomarker for hepatocellular carcinoma in patients with chronic hepatitis B virus infection: a retrospective cohort study.
Journal: Scientific reports
Published: December 25, 2023
EphA2 Proteolytic Fragment as a Sensitive Diagnostic Biomarker for Very Early-stage Pancreatic Ductal Carcinoma.
Journal: Cancer research communications
Published: February 17, 2023
Serum Laminin γ2 Monomer as a Diagnostic and Predictive Biomarker for Hepatocellular Carcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: June 19, 2020
Unique Biological Activity and Potential Role of Monomeric Laminin-γ2 as a Novel Biomarker for Hepatocellular Carcinoma: A Review.
Journal: International journal of molecular sciences
Published: November 15, 2018
Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer.
Journal: Biomarker research
Published: July 17, 2017
Serum monomeric laminin-γ2 as a novel biomarker for hepatocellular carcinoma.
Journal: Cancer science
Published: January 10, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026